+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biomaterial Wound Dressing Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • March 2022
  • Region: Global
  • TechNavio
  • ID: 5561268
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the biomaterial wound dressing market and it is poised to grow by $90.49 mn during 2022-2026, progressing at a CAGR of 6.11% during the forecast period. The report on the biomaterial wound dressing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of sports injuries and chronic wounds, the rising number of surgical procedures worldwide, and demand for fast and safe treatment for chronic wounds.

The biomaterial wound dressing market analysis includes the type segment and geographic landscape.

The biomaterial wound dressing market is segmented as below:


By Type


  • Antimicrobial dressings
  • Bio-engineered skin and skin substitutes

By Geographical Landscape


  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the significant demand from the geriatric population as one of the prime reasons driving the biomaterial wound dressing market growth during the next few years. Also, increasing participation in adventurous and recreational activities and increasing prevalence of lifestyle disorders such as diabetes leading to venous leg ulcers, pressure ulcers, and diabetic foot ulcers will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on biomaterial wound dressing market covers the following areas:
  • Biomaterial wound dressing market sizing
  • Biomaterial wound dressing market forecast
  • Biomaterial wound dressing market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biomaterial wound dressing market vendors that include 3M Co., AdvaCare International, B. Braun Melsungen AG, Baxter International Inc., Cardinal Health Inc., Coloplast Corp., DermaRite Industries LLC, Hollister Inc., Integra LifeSciences Corp., Johnson and Johnson Inc., Medline Industries Inc., Molnlycke Health Care AB, Nidhi Surgicals Pvt. Ltd., Paul Hartmann AG, Scapa Group Plc, Smith and Nephew plc, URGO Group, Vericel Corp., ConvaTec Group Plc, and Informa Plc. Also, the biomaterial wound dressing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Antimicrobial dressings - Market size and forecast 2021-2026
Exhibit 28: Chart on Antimicrobial dressings - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Antimicrobial dressings - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Antimicrobial dressings - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Antimicrobial dressings - Year-over-year growth 2021-2026 (%)
5.4 Bio-engineered skin and skin substitutes - Market size and forecast 2021-2026
Exhibit 32: Chart on Bio-engineered skin and skin substitutes - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Bio-engineered skin and skin substitutes - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Bio-engineered skin and skin substitutes - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Bio-engineered skin and skin substitutes - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 France - Market size and forecast 2021-2026
Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%)
7.10 Japan - Market size and forecast 2021-2026
Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 3M Co.
Exhibit 85: 3M Co. - Overview
Exhibit 86: 3M Co. - Business segments
Exhibit 87: 3M Co. - Key news
Exhibit 88: 3M Co. - Key offerings
Exhibit 89: 3M Co. - Segment focus
10.4 B. Braun Melsungen AG
Exhibit 90: B. Braun Melsungen AG - Overview
Exhibit 91: B. Braun Melsungen AG - Business segments
Exhibit 92: B. Braun Melsungen AG - Key news
Exhibit 93: B. Braun Melsungen AG - Key offerings
Exhibit 94: B. Braun Melsungen AG - Segment focus
10.5 Cardinal Health Inc.
Exhibit 95: Cardinal Health Inc. - Overview
Exhibit 96: Cardinal Health Inc. - Business segments
Exhibit 97: Cardinal Health Inc. - Key news
Exhibit 98: Cardinal Health Inc. - Key offerings
Exhibit 99: Cardinal Health Inc. - Segment focus
10.6 ConvaTec Group Plc
Exhibit 100: ConvaTec Group Plc - Overview
Exhibit 101: ConvaTec Group Plc - Business segments
Exhibit 102: ConvaTec Group Plc - Key offerings
Exhibit 103: ConvaTec Group Plc - Segment focus
10.7 DermaRite Industries LLC
Exhibit 104: DermaRite Industries LLC - Overview
Exhibit 105: DermaRite Industries LLC - Product / Service
Exhibit 106: DermaRite Industries LLC - Key offerings
10.8 Hollister Inc.
Exhibit 107: Hollister Inc. - Overview
Exhibit 108: Hollister Inc. - Product / Service
Exhibit 109: Hollister Inc. - Key offerings
10.9 Integra LifeSciences Corp.
Exhibit 110: Integra LifeSciences Corp. - Overview
Exhibit 111: Integra LifeSciences Corp. - Business segments
Exhibit 112: Integra LifeSciences Corp. - Key news
Exhibit 113: Integra LifeSciences Corp. - Key offerings
Exhibit 114: Integra LifeSciences Corp. - Segment focus
10.10 Johnson and Johnson Inc.
Exhibit 115: Johnson and Johnson Inc. - Overview
Exhibit 116: Johnson and Johnson Inc. - Business segments
Exhibit 117: Johnson and Johnson Inc. - Key news
Exhibit 118: Johnson and Johnson Inc. - Key offerings
Exhibit 119: Johnson and Johnson Inc. - Segment focus
10.11 Molnlycke Health Care AB
Exhibit 120: Molnlycke Health Care AB - Overview
Exhibit 121: Molnlycke Health Care AB - Product / Service
Exhibit 122: Molnlycke Health Care AB - Key offerings
10.12 Smith and Nephew plc
Exhibit 123: Smith and Nephew plc - Overview
Exhibit 124: Smith and Nephew plc - Business segments
Exhibit 125: Smith and Nephew plc - Key news
Exhibit 126: Smith and Nephew plc - Key offerings
Exhibit 127: Smith and Nephew plc - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 128: Inclusions checklist
Exhibit 129: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 130: Currency conversion rates for US$
11.4 Research methodology
Exhibit 131: Research methodology
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
11.5 List of abbreviations
Exhibit 134: List of abbreviations
vendors in the market have been selected based on their brand presence, geographic reach, and related segmental revenues
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Incremental Growth
Exhibit 7: Executive Summary - Data Table on Incremental Growth
Exhibit 8: Executive Summary - Chart on Vendor Market Positioning
Exhibit 9: Parent market
Exhibit 10: Market Characteristics
Exhibit 11: Offerings of vendors included in the market definition
Exhibit 12: Market segments
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
Exhibit 28: Chart on Antimicrobial dressings - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Antimicrobial dressings - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Antimicrobial dressings - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Antimicrobial dressings - Year-over-year growth 2021-2026 (%)
Exhibit 32: Chart on Bio-engineered skin and skin substitutes - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Bio-engineered skin and skin substitutes - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Bio-engineered skin and skin substitutes - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Bio-engineered skin and skin substitutes - Year-over-year growth 2021-2026 (%)
Exhibit 36: Market opportunity by Type ($ million)
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
Exhibit 81: Overview on factors of disruption
Exhibit 82: Impact of key risks on business
Exhibit 83: Vendors covered
Exhibit 84: Matrix on vendor position and classification
Exhibit 85: 3M Co. - Overview
Exhibit 86: 3M Co. - Business segments
Exhibit 87: 3M Co. - Key news
Exhibit 88: 3M Co. - Key offerings
Exhibit 89: 3M Co. - Segment focus
Exhibit 90: B. Braun Melsungen AG - Overview
Exhibit 91: B. Braun Melsungen AG - Business segments
Exhibit 92: B. Braun Melsungen AG - Key news
Exhibit 93: B. Braun Melsungen AG - Key offerings
Exhibit 94: B. Braun Melsungen AG - Segment focus
Exhibit 95: Cardinal Health Inc. - Overview
Exhibit 96: Cardinal Health Inc. - Business segments
Exhibit 97: Cardinal Health Inc. - Key news
Exhibit 98: Cardinal Health Inc. - Key offerings
Exhibit 99: Cardinal Health Inc. - Segment focus
Exhibit 100: ConvaTec Group Plc - Overview
Exhibit 101: ConvaTec Group Plc - Business segments
Exhibit 102: ConvaTec Group Plc - Key offerings
Exhibit 103: ConvaTec Group Plc - Segment focus
Exhibit 104: DermaRite Industries LLC - Overview
Exhibit 105: DermaRite Industries LLC - Product / Service
Exhibit 106: DermaRite Industries LLC - Key offerings
Exhibit 107: Hollister Inc. - Overview
Exhibit 108: Hollister Inc. - Product / Service
Exhibit 109: Hollister Inc. - Key offerings
Exhibit 110: Integra LifeSciences Corp. - Overview
Exhibit 111: Integra LifeSciences Corp. - Business segments
Exhibit 112: Integra LifeSciences Corp. - Key news
Exhibit 113: Integra LifeSciences Corp. - Key offerings
Exhibit 114: Integra LifeSciences Corp. - Segment focus
Exhibit 115: Johnson and Johnson Inc. - Overview
Exhibit 116: Johnson and Johnson Inc. - Business segments
Exhibit 117: Johnson and Johnson Inc. - Key news
Exhibit 118: Johnson and Johnson Inc. - Key offerings
Exhibit 119: Johnson and Johnson Inc. - Segment focus
Exhibit 120: Molnlycke Health Care AB - Overview
Exhibit 121: Molnlycke Health Care AB - Product / Service
Exhibit 122: Molnlycke Health Care AB - Key offerings
Exhibit 123: Smith and Nephew plc - Overview
Exhibit 124: Smith and Nephew plc - Business segments
Exhibit 125: Smith and Nephew plc - Key news
Exhibit 126: Smith and Nephew plc - Key offerings
Exhibit 127: Smith and Nephew plc - Segment focus
Exhibit 128: Inclusions checklist
Exhibit 129: Exclusions checklist
Exhibit 130: Currency conversion rates for US$
Exhibit 131: Research methodology
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
Exhibit 134: List of abbreviations

Executive Summary

The publisher announces the Publication of its Research Report - Global Biomaterial Wound Dressing Market 2022-2026

The publisher recognizes the following companies as the key players in the global biomaterial wound dressing market: 3M Co., AdvaCare International, B. Braun Melsungen AG, Baxter International Inc., Cardinal Health Inc., Coloplast Corp., DermaRite Industries LLC, Hollister Inc., Integra LifeSciences Corp., Johnson and Johnson Inc., Medline Industries Inc., Molnlycke Health Care AB, Nidhi Surgicals Pvt. Ltd., Paul Hartmann AG, Scapa Group Plc, Smith and Nephew plc, URGO Group, Vericel Corp., ConvaTec Group Plc, and Informa Plc.

Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is significant demand from the geriatric population.'

According to the report, one of the major drivers for this market is the increasing incidence of sports injuries and chronic wounds.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M Co.
  • AdvaCare International
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cardinal Health Inc.
  • Coloplast Corp.
  • DermaRite Industries LLC
  • Hollister Inc.
  • Integra LifeSciences Corp.
  • Johnson and Johnson Inc.
  • Medline Industries Inc.
  • Molnlycke Health Care AB
  • Nidhi Surgicals Pvt. Ltd.
  • Paul Hartmann AG
  • Scapa Group Plc
  • Smith and Nephew plc
  • URGO Group
  • Vericel Corp.
  • ConvaTec Group Plc
  • Informa Plc